Abstract:Objective Reduced Paneth cell (PC) numbers are observed in inflammatory bowel diseases and impaired PC function contributes to the ileal pathogenesis of Crohn’s disease (CD). PCs reside in proximity to Lgr5 + intestinal stem cells (ISC) and mitochondria are critical for ISC-renewal and differentiation. Here, we characterise ISC and PC appearance under inflammatory conditions and describe the role of mitochondrial function for ISC niche-maintenance. Design Ileal tissue samples from patients with CD, mouse models for mitochondrial dysfunction (Hsp60 Δ/ΔISC ) and CD-like ileitis (TNF ΔARE ), and intestinal organoids were used to characterise PCs and ISCs in relation to mitochondrial function. Results In patients with CD and TNF ΔARE mice, inflammation correlated with reduced numbers of Lysozyme-positive granules in PCs and decreased Lgr5 expression in crypt regions. Disease-associated changes in PC and ISC appearance persisted in non-inflamed tissue regions of patients with CD and predicted the risk of disease recurrence after surgical resection. ISC-specific deletion of Hsp60 and inhibition of mitochondrial respiration linked mitochondrial function to the aberrant PC phenotype. Consistent with reduced stemness in vivo, crypts from inflamed TNF ΔARE mice fail to grow into organoids ex vivo. Dichloroacetate-mediated inhibition of glycolysis, forcing cells to shift to mitochondrial respiration, improved ISC niche function and rescued the ability of TNF ΔARE mice-derived crypts to form organoids. Conclusion We provide evidence that inflammation-associated mitochondrial dysfunction in the intestinal epithelium triggers a metabolic imbalance, causing reduced stemness and acquisition of a dysfunctional PC phenotype. Blocking glycolysis might be a novel drug target to antagonise PC dysfunction in the pathogenesis of CD.

Mitochondrial function — gatekeeper of intestinal epithelial cell homeostasis

Mitochondrial Metabolism in the Intestinal Stem Cell Niche—Sensing and Signaling in Health and Disease

Mitochondrial function and gastrointestinal diseases

Intestinal epithelial cell metabolism at the interface of microbial dysbiosis and tissue injury

The role of microbiota-mitochondria crosstalk in pathogenesis and therapy of intestinal diseases

Mitochondrial Control of Innate Immune Responses

Mitochondria maintain controlled activation state of epithelial-resident T lymphocytes

Gut bacteria signaling to mitochondria in intestinal inflammation and cancer

[Role of Mitochondria in Intestinal Epithelial Barrier Dysfunction in Inflammatory Bowel Disease]

Macrophage orchestration of epithelial and stromal cell homeostasis in the intestine

Mitochondrial perturbation in the intestine causes microbiota-dependent injury and gene signatures discriminative of inflammatory disease

Mitochondrial impairment drives intestinal stem cell transition into dysfunctional Paneth cells predicting Crohn’s disease recurrence

The intestinal epithelial-macrophage-crypt stem cell axis plays a crucial role in regulating and maintaining intestinal homeostasis

Mitochondria: It is all about energy

Mitochondria and the dynamic control of stem cell homeostasis

Multifaceted mitochondria in innate immunity

Intestinal stem cells: guardians of homeostasis in health and aging amid environmental challenges

Mitochondria of Intestinal Epithelial Cells in Depression: Are They at A Crossroads of Gut-brain Communication?

Intracellular to Interorgan Mitochondrial Communication in Striated Muscle in Health and Disease

Intestinal epithelial cells: at the interface of the microbiota and mucosal immunity